David Thomas

David Thomas is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of respiratory diseases and male infertility. With a total of 2 patents, his work is paving the way for innovative therapeutic solutions.

Latest Patents

David Thomas's latest patents focus on a compound designed to treat or prevent various diseases and conditions. These include cystic fibrosis, chronic obstructive pulmonary disease (COPD), asthma, and several others. The compound, identified as 9,10-dimethoxy-2-(2,4,6-trimethylphenylimino)-3-(N-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one, is aimed at modulating CFTR activity. Additionally, his inventions include compositions that combine this compound with leukotriene receptor antagonists and CFTR potentiators or correctors.

Career Highlights

David Thomas is currently associated with Verona Pharma Plc, where he continues to advance his research and development efforts. His work is crucial in addressing unmet medical needs in respiratory health and fertility.

Collaborations

Some of his notable coworkers include Katharine Abbott-Banner and John Hanrahan, who contribute to the innovative environment at Verona Pharma Plc.

Conclusion

David Thomas exemplifies the spirit of innovation in the pharmaceutical industry, with his patents offering promising avenues for treating complex health conditions. His contributions are vital for future advancements in medical treatments.

Profile summary based on public USPTO records.